IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MICHAEL S MOORE

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health

NPI
1588339923
CMS profile
10643681
Location
MESA, AZ

General Payments · PY2022–2024

$1,943.33

  • Reported across 61 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,584.23

52 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Psychiatric/Mental Health AZ All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,584.23 52

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Alkermes, Inc. $363.29 9
Teva Pharmaceuticals USA, Inc. $251.55 14
Janssen Pharmaceuticals, Inc $224.94 5
E.R. Squibb & Sons, L.L.C. $188.24 6
Otsuka America Pharmaceutical, Inc. $154.28 6
Neurocrine BioSciences, Inc. $136.27 4
Axsome Therapeutics, Inc. $115.92 1
ITI, Inc. $78.33 4
Indivior Inc. $41.95 2
ABBVIE INC. $29.46 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2022 $21.90 1
PY2023 $337.20 8
PY2024 $1,584.23 52

Payment records · PY2024 (52)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $29.46 10/03/2024 Food and Beverage Undisputed 01/23/2026 1107687116 CMS
Alkermes, Inc. $22.85 04/10/2024 Food and Beverage Undisputed 01/23/2026 1120557679 CMS
Alkermes, Inc. $110.30 04/23/2024 Food and Beverage Undisputed 01/23/2026 1120557681 CMS
Alkermes, Inc. $19.09 07/07/2024 Food and Beverage Undisputed 01/23/2026 1120557683 CMS
Alkermes, Inc. $19.32 08/23/2024 Food and Beverage Undisputed 01/23/2026 1120557685 CMS
Alkermes, Inc. $15.99 09/12/2024 Food and Beverage Undisputed 01/23/2026 1120557687 CMS
Alkermes, Inc. $20.20 10/29/2024 Food and Beverage Undisputed 01/23/2026 1120557689 CMS
Alkermes, Inc. $109.91 11/14/2024 Food and Beverage Undisputed 01/23/2026 1120557691 CMS
Alkermes, Inc. $13.52 11/22/2024 Food and Beverage Undisputed 01/23/2026 1120557693 CMS
Alkermes, Inc. $32.11 12/04/2024 Food and Beverage Undisputed 01/23/2026 1120557695 CMS
Axsome Therapeutics, Inc. $115.92 12/10/2024 Food and Beverage Undisputed 01/23/2026 1148393651 CMS
E.R. Squibb & Sons, L.L.C. $20.20 11/07/2024 Food and Beverage Undisputed 01/23/2026 1101632266 CMS
E.R. Squibb & Sons, L.L.C. $6.61 11/12/2024 Food and Beverage Undisputed 01/23/2026 1101632262 CMS
E.R. Squibb & Sons, L.L.C. $10.93 11/19/2024 Food and Beverage Undisputed 01/23/2026 1101632273 CMS
E.R. Squibb & Sons, L.L.C. $127.87 11/19/2024 Food and Beverage Undisputed 01/23/2026 1101632299 CMS
E.R. Squibb & Sons, L.L.C. $7.67 12/03/2024 Food and Beverage Undisputed 01/23/2026 1101632284 CMS
E.R. Squibb & Sons, L.L.C. $14.96 12/17/2024 Food and Beverage Undisputed 01/23/2026 1101632302 CMS
Indivior Inc. $16.96 04/25/2024 Food and Beverage Undisputed 01/23/2026 1144564103 CMS
Indivior Inc. $24.99 09/11/2024 Food and Beverage Undisputed 01/23/2026 1144564105 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $14.57 09/06/2024 Food and Beverage Undisputed 01/23/2026 1143558069 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $17.62 10/18/2024 Food and Beverage Undisputed 01/23/2026 1143558073 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $23.71 11/22/2024 Food and Beverage Undisputed 01/23/2026 1143558076 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $22.43 12/06/2024 Food and Beverage Undisputed 01/23/2026 1143558081 CMS
Janssen Pharmaceuticals, Inc $124.98 08/14/2024 Food and Beverage Undisputed 01/23/2026 1077916177 CMS
Janssen Pharmaceuticals, Inc $25.51 08/23/2024 Food and Beverage Undisputed 01/23/2026 1077916533 CMS
Janssen Pharmaceuticals, Inc $17.71 09/13/2024 Food and Beverage Undisputed 01/23/2026 1077916375 CMS
Janssen Pharmaceuticals, Inc $30.46 10/25/2024 Food and Beverage Undisputed 01/23/2026 1077916395 CMS
Janssen Pharmaceuticals, Inc $26.28 12/20/2024 Food and Beverage Undisputed 01/23/2026 1077916229 CMS
Neurocrine Biosciences, Inc. $7.84 11/27/2024 Food and Beverage Undisputed 01/23/2026 1151017705 CMS
Neurocrine Biosciences, Inc. $114.41 12/03/2024 Food and Beverage Undisputed 01/23/2026 1150924074 CMS
Neurocrine Biosciences, Inc. $10.65 12/19/2024 Food and Beverage Undisputed 01/23/2026 1151014044 CMS
Neurocrine Biosciences, Inc. $3.37 12/19/2024 Food and Beverage Undisputed 01/23/2026 1151025681 CMS
Otsuka America Pharmaceutical, Inc. $8.98 02/29/2024 Food and Beverage Undisputed 01/23/2026 1119142773 CMS
Otsuka America Pharmaceutical, Inc. $14.75 05/22/2024 Food and Beverage Undisputed 01/23/2026 1119142775 CMS
Otsuka America Pharmaceutical, Inc. $17.78 08/08/2024 Food and Beverage Undisputed 01/23/2026 1119142777 CMS
Otsuka America Pharmaceutical, Inc. $12.47 09/03/2024 Food and Beverage Undisputed 01/23/2026 1119142779 CMS
Otsuka America Pharmaceutical, Inc. $90.15 10/25/2024 Food and Beverage Undisputed 01/23/2026 1119142781 CMS
Otsuka America Pharmaceutical, Inc. $10.15 12/05/2024 Food and Beverage Undisputed 01/23/2026 1119142783 CMS
Teva Pharmaceuticals USA, Inc. $16.76 01/24/2024 Food and Beverage Undisputed 01/23/2026 1151452563 CMS
Teva Pharmaceuticals USA, Inc. $27.65 02/20/2024 Food and Beverage Undisputed 01/23/2026 1151452565 CMS
Teva Pharmaceuticals USA, Inc. $5.84 03/28/2024 Food and Beverage Undisputed 01/23/2026 1151452589 CMS
Teva Pharmaceuticals USA, Inc. $19.55 03/28/2024 Food and Beverage Undisputed 01/23/2026 1151452591 CMS
Teva Pharmaceuticals USA, Inc. $26.98 05/07/2024 Food and Beverage Undisputed 01/23/2026 1151452619 CMS
Teva Pharmaceuticals USA, Inc. $21.03 06/06/2024 Food and Beverage Undisputed 01/23/2026 1151452637 CMS
Teva Pharmaceuticals USA, Inc. $21.65 08/28/2024 Food and Beverage Undisputed 01/23/2026 1151452813 CMS
Teva Pharmaceuticals USA, Inc. $2.52 09/10/2024 Food and Beverage Undisputed 01/23/2026 1151452815 CMS
Teva Pharmaceuticals USA, Inc. $18.67 09/10/2024 Food and Beverage Undisputed 01/23/2026 1151452817 CMS
Teva Pharmaceuticals USA, Inc. $8.49 09/18/2024 Food and Beverage Undisputed 01/23/2026 1151452819 CMS
Teva Pharmaceuticals USA, Inc. $31.96 10/15/2024 Food and Beverage Undisputed 01/23/2026 1151452835 CMS
Teva Pharmaceuticals USA, Inc. $18.14 11/06/2024 Food and Beverage Undisputed 01/23/2026 1151452837 CMS
Teva Pharmaceuticals USA, Inc. $27.07 11/13/2024 Food and Beverage Undisputed 01/23/2026 1151452839 CMS
Teva Pharmaceuticals USA, Inc. $5.24 11/25/2024 Food and Beverage Undisputed 01/23/2026 1151452847 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.